| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |